Opportunistic Infections Citation List:
May 27 - June 9, 2011
ANTIFUNGAL COMPOUNDS ( includes Cryptococcus, Aspergillus, Candida, & Histoplasma)
1. Synthesis of 4-Hydroxycoumarin Heteroarylhybrids as Potential Antimicrobial Agents. Siddiqui, Z.N., N.M. T, A. Ahmad, and A.U. Khan. Archiv Der Pharmazie, 2011. 344(6): p. 394-401; PMID[21647940].
[Pubmed]. OI_0527-060911.
2. Two Antimicrobial and Nematicidal Peptides Derived from Sequences Encoded Picea sitchensis. Liu, R., L. Mu, H. Liu, L. Wei, T. Yan, M. Chen, K. Zhang, J. Li, D. You, and R. Lai. Journal of Peptide Science, 2011. [Epub ahead of print]; PMID[21644248].
[Pubmed]. OI_0527-060911.
3. Synthesis and In-vitro Antimicrobial Activity of Secondary and Tertiary Amines Containing 2-Chloro-6-methylquinoline Moiety. Kumar, S., S. Bawa, D. Kaushik, and B.P. Panda. Archiv Der Pharmazie, 2011. [Epub ahead of print]; PMID[21618272].
[Pubmed]. OI_0527-060911.
4. A Physico-Chemical and Biological Study of Novel Chitosan-Chloroquinoline Derivative for Biomedical Applications. Kumar, S., P.K. Dutta, and J. Koh. International Journal of Biological Macromolecules, 2011. [Epub ahead of print]; PMID[21640132].
[Pubmed]. OI_0527-060911.
5. Antifungal Activity of Redox-Active Benzaldehydes that Target Cellular Antioxidation. Kim, J.H., K.L. Chan, N. Mahoney, and B.C. Campbell. Annals of Clinical Microbiology and Antimicrobials, 2011. 10(1): p. 23; PMID[21627838].
[Pubmed]. OI_0527-060911.
6. Phytochemical Analysis and Antimicrobial Activities of Methanolic Extracts of Leaf, Stem and Root from Different Varieties of Labisa pumila Benth. Karimi, E., H.Z. Jaafar, and S. Ahmad. Molecules, 2011. 16(6): p. 4438-4450; PMID[21623314].
[Pubmed]. OI_0527-060911.
7. Effect of Licorice Compounds Licochalcone A, Glabridin and Glycyrrhizic acid on Growth and Virulence Properties of Candida albicans. Messier, C. and D. Grenier. Mycoses, 2011. [Epub ahead of print]; PMID[21615543].
[Pubmed]. OI_0527-060911.
8. In vitro Antifungal Evaluation and Structure-Activity Relationship of Diphenyl Diselenide and Synthetic Analogues. Loreto, E.S., D.A. Nunes Mario, J.M. Santurio, S.H. Alves, C.W. Nogueira, and G. Zeni. Mycoses, 2011. [Epub ahead of print]; PMID[21615531].
[Pubmed]. OI_0527-060911.
9. Synthesis, Characterization, and Antimicrobial Evaluation of Oxadiazole Congeners. Sadek, B. and K.M. Fahelelbom. Molecules, 2011. 16(6): p. 4339-4347; PMID[21613975].
[Pubmed]. OI_0527-060911.
10. Chemical Reactivity and Antimicrobial Activity of N-Substituted Maleimides. Salewska, N., J. Boros-Majewska, I. Lacka, K. Chylinska, M. Sabisz, S. Milewski, and M.J. Milewska. Journal of Enzyme Inhibition and Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21612375].
[Pubmed]. OI_0527-060911.
11. Synthesis and Characterization of New Types of Halogenated and Alkylated Imidazolidineiminothiones and a Comparative Study of their Antitumor, Antibacterial, and Antifungal Activities. Moussa, Z., M.A. El-Sharief, and A.M. El-Sharief. European Journal of Medicinal Chemistry, 2011. 46(6): p. 2280-2289; PMID[21440963].
[Pubmed]. OI_0527-060911.
ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)
12. New Classes of Alanine Racemase Inhibitors Identified by High-Throughput Screening Show Antimicrobial Activity against Mycobacterium tuberculosis. Anthony, K.G., U. Strych, K.R. Yeung, C.S. Shoen, O. Perez, K.L. Krause, M.H. Cynamon, P.A. Aristoff, and R.A. Koski. Plos One, 2011. 6(5): p. e20374; PMID[21637807].
[Pubmed]. OI_0527-060911.
13. Targeting Tuberculosis Through a Small Focused Library of 1,2,3-Triazoles. Labadie, G.R., A. de la Iglesia, and H.R. Morbidoni. Molecular Diversity, 2011. [Epub ahead of print]; PMID[21633789].
[Pubmed]. OI_0527-060911.
14. Novel Inhibitors of InhA Efficiently Kill Mycobacterium tuberculosis under Aerobic and Anaerobic Conditions. Vilcheze, C., A.D. Baughn, J. Tufariello, L. Leung, M. Kuo, C. Basler, D. Alland, J.C. Sacchettini, J.S. Freundlich, and W.R. Jacobs, Jr. Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[21628538].
[Pubmed]. OI_0527-060911.
15. Interaction of N-methyl-2-alkenyl-4-quinolones with ATP-dependent MurE ligase of Mycobacterium tuberculosis: antibacterial activity, molecular docking and inhibition kinetics. Guzman, J.D., A. Wube, D. Evangelopoulos, A. Gupta, A. Hufner, C. Basavannacharya, M.M. Rahman, C. Thomaschitz, R. Bauer, T.D. McHugh, I. Nobeli, J.M. Prieto, S. Gibbons, F. Bucar, and S. Bhakta. Journal of Antimicrobial Chemotherapy, 2011. [Epub ahead of print]; PMID[21622974].
[Pubmed]. OI_0527-060911.
16. Antimycobacterial activity of Novel 1,2,4-Oxadiazole-pyranopyridine/Chromene Hybrids Generated by Chemoselective 1,3-Dipolar Cycloadditions of Nitrile oxides. Ranjith Kumar, R., S. Perumal, J.C. Menendez, P. Yogeeswari, and D. Sriram. Bioorganic and Medicinal Chemistry, 2011. 19(11): p. 3444-3450; PMID[21592801].
[Pubmed]. OI_0527-060911.
17. Synthesis and Antimycobacterial Activities of Non-purine Analogs of 6-Aryl-9-benzylpurines: Imidazopyridines, Pyrrolopyridines, Benzimidazoles, and Indoles. Khoje, A.D., C. Charnock, B. Wan, S. Franzblau, and L.L. Gundersen. Bioorganic & Medicinal Chemistry, 2011. 19(11): p. 3483-3491; PMID[21546254].
[Pubmed]. OI_0527-060911.
18. New Quinolin-4-yl-1,2,3-triazoles Carrying Amides, Sulphonamides and Amidopiperazines as Potential Antitubercular Agents. Thomas, K.D., A.V. Adhikari, I.H. Chowdhury, E. Sumesh, and N.K. Pal. European Journal of Medicinal Chemistry, 2011. 46(6): p. 2503-2512; PMID[21489660].
[Pubmed]. OI_0527-060911.
19. Antituberculosis Cycloartane Triterpenoids from Radermachera boniana. Truong, N.B., C.V. Pham, H.T. Doan, H.V. Nguyen, C.M. Nguyen, H.T. Nguyen, H.J. Zhang, H.H. Fong, S.G. Franzblau, D.D. Soejarto, and M.V. Chau. Journal of Natural Products, 2011. 74(5): p. 1318-1322; PMID[21469696].
[Pubmed]. OI_0527-060911.
20. Effects of Hydroxypropyl-beta-cyclodextrin on Cell Growth, Activity, and Integrity of Steroid-transforming Arthrobacter simplex and Mycobacterium sp. Shen, Y., M. Wang, L. Zhang, Y. Ma, B. Ma, Y. Zheng, H. Liu, and J. Luo. Applied Microbiology and Biotechnology, 2011. 90(6): p. 1995-2003; PMID[21468712].
[Pubmed]. OI_0527-060911.
21. Inhibition of Mycobacterium tuberculosis Methionine Aminopeptidases by Bengamide Derivatives. Lu, J.P., X.H. Yuan, H. Yuan, W.L. Wang, B. Wan, S.G. Franzblau, and Q.Z. Ye. ChemMedChem, 2011. 6(6): p. 1041-1048; PMID[21465667].
[Pubmed]. OI_0527-060911.
22. Efficacy of Antimicrobial Peptoids against Mycobacterium tuberculosis. Kapoor, R., P.R. Eimerman, J.W. Hardy, J.D. Cirillo, C.H. Contag, and A.E. Barron. Antimicrobial Agents and Chemotherapy, 2011. 55(6): p. 3058-62; PMID[21464254].
[Pubmed]. OI_0527-060911.
23. Facile Transformation of Biginelli Pyrimidin-2(1H)-ones to Pyrimidines. Singh, K., B. Wan, S. Franzblau, K. Chibale, and J. Balzarini. In vitro evaluation as inhibitors of Mycobacterium tuberculosis and modulators of cytostatic activity. European Journal of Medicinal Chemistry, 2011. 46(6): p. 2290-2294; PMID[21450375].
[Pubmed]. OI_0527-060911.
24. 2,3-Dideoxy hex-2-enopyranosid-4-uloses as Promising New Anti-tubercular Agents: Design, Synthesis, Biological Evaluation and SAR Studies. Saquib, M., I. Husain, S. Sharma, G. Yadav, V.K. Singh, S.K. Sharma, P. Shah, M.I. Siddiqi, B. Kumar, J. Lal, G.K. Jain, B.S. Srivastava, R. Srivastava, and A.K. Shaw. European Journal of Medicinal Chemistry, 2011. 46(6): p. 2217-2223; PMID[21440336].
[Pubmed]. OI_0527-060911.
25. Synthesis of N-substituted 2-[(1E)-alkenyl]-4-(1H)-quinolone Derivatives as Antimycobacterial Agents against Non-tubercular Mycobacteria. Wube, A.A., F. Bucar, C. Hochfellner, M. Blunder, R. Bauer, and A. Hufner. European Journal of Medicinal Chemistry, 2011. 46(6): p. 2091-2101; PMID[21429630].
[Pubmed]. OI_0527-060911.
26. Synthesis and Anti-Mycobacterium tuberculosis Evaluation of Aza-Stilbene Derivatives. Pavan, F., G.S. de Carvalho, A.D. da Silva, and C.Q. Leite. TheScientificWorldJournal, 2011. 11: p. 1113-1119; PMID[21623457].
[Pubmed]. OI_0527-060911.
ANTIMALARIAL COMPOUNDS (Plasmodium spp.)
27. Imidazolopiperazines (I): Optimization for New Antimalarial Agents. Wu, T., A. Nagle, K. Kuhen, K. Gagaring, R. Borboa, C. Francek, Z. Chen, D. Plouffe, A. Goh, S.B. Lakshminarayana, J. Wu, H.Q. Ang, P. Zeng, M.L. Kang, W. Tan, M. Tan, N. Ye, X. Lin, C. Caldwell, J. Ek, S. Skolnik, F. Liu, J. Wang, J. Chang, C. Li, T. Hollenbeck, T. Tuntland, J. Isbell, C. Fischli, R. Brun, M. Rottmann, V. Dartois, T. Keller, T. Diagana, E. Winzeler, R. Glynne, D.C. Tully, and A.K. Chatterjee.. Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21644570].
[Pubmed]. OI_0527-060911.
28. Antiplasmodial Properties of Acyl-lysyl Oligomers in Culture and Animal Models of Malaria. Zaknoon, F., S. Wein, M. Krugliak, O. Meir, S. Rotem, H. Ginsburg, H. Vial, and A. Mor. Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[21646484].
[Pubmed]. OI_0527-060911.
29. Antimalarial Pyrido[1,2-a]benzimidazoles. Ndakala, A.J., R.K. Gessner, P.W. Gitari, N. October, K.L. White, A. Hudson, F. Fakorede, D.M. Shackleford, M. Kaiser, C.L. Yeates, S.A. Charman, and K. Chibale. Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21644541].
[Pubmed]. OI_0527-060911.
30. Antiplasmodial Potential of Medicinal Plant Extracts from Malaiyur and Javadhu Hills of South India. Kamaraj, C., N.K. Kaushik, D. Mohanakrishnan, G. Elango, A. Bagavan, A.A. Zahir, A.A. Rahuman, and D. Sahal. Parasitology Research, 2011. [Epub ahead of print]; PMID[21643655].
[Pubmed]. OI_0527-060911.
31. Synthesis and Antimalarial Activity of 2-Guanidino-4-oxoimidazoline Derivatives. Liu, X., X. Wang, Q. Li, M.P. Kozar, V. Melendez, M.T. O'Neil, and A.J. Lin. Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21627120].
[Pubmed]. OI_0527-060911.
32. Synthesis and Antimalarial Activity of Novel Dihydro-artemisinin Derivatives. Liu, Y., K. Cui, W. Lu, W. Luo, J. Wang, J. Huang, and C. Guo. Molecules, 2011. 16(6): p. 4527-4538; PMID[21629181].
[Pubmed]. OI_0527-060911.
33. Tandem Allylic Oxidation-Condensation/Esterification Catalyzed by Silica Gel: An Expeditious Approach Towards Antimalarial Diaryldienones and Enones from Natural Methoxylated phenylpropenes. Sharma, A., N. Sharma, A. Shard, R. Kumar, D. Mohanakrishnan, Saima, A.K. Sinha, and D. Sahal. Organic & Biomolecular Chemistry, 2011. [Epub ahead of print]; PMID[21625717].
[Pubmed]. OI_0527-060911.
34. Isoflavone Dimers and Other Bioactive Constituents from the Figs of Ficus mucuso. Bankeu, J.J., R. Khayala, B.N. Lenta, D.T. Noungoue, S.A. Ngouela, S.A. Mustafa, K. Asaad, M.I. Choudhary, S.T. Prigge, R. Hasanov, A.E. Nkengfack, E. Tsamo, and M.S. Ali. Journal of Natural Products, 2011. [Epub ahead of print]; PMID[21619045].
[Pubmed]. OI_0527-060911.
35. Anti-malarial, Anti-trypanosomal, and Anti-leishmanial Activities of Jacaranone Isolated from Pentacalia desiderabilis (Vell.) Cuatrec. (Asteraceae). Morais, T.R., P. Romoff, O.A. Favero, J.Q. Reimao, W.C. Lourenco, A.G. Tempone, A.D. Hristov, S.M. Di Santi, J.H. Lago, P. Sartorelli, and M.J. Ferreira. Parasitology Research, 2011. [Epub ahead of print]; PMID[21614544].
[Pubmed]. OI_0527-060911.
36. Identification of Plasmepsin Inhibitors as Selective Anti-malarial Agents using Ligand Based Drug Design. McKay, P.B., M.B. Peters, G. Carta, C.T. Flood, E. Dempsey, A. Bell, C. Berry, D.G. Lloyd, and D. Fayne. Bioorganic & Medicinal Chemistry Letters, 2011. 21(11): p. 3335-3341; PMID[21531557].
[Pubmed]. OI_0527-060911.
37. Expeditious Synthesis and Biological Evaluation of Novel 2,N(6)-Disubstituted 1,2-dihydro-1,3,5-triazine-4,6-diamines as Potential Antimalarials. Gravestock, D., A.L. Rousseau, A.C. Lourens, S.S. Moleele, R.L. van Zyl, and P.A. Steenkamp. European Journal of Medicinal Chemistry, 2011. 46(6): p. 2022-2030; PMID[21420762].
[Pubmed]. OI_0527-060911.
38. New Antiplasmodial Indole alkaloids from Hunteria zeylanica. Nugroho, A.E., M. Sugai, Y. Hirasawa, T. Hosoya, K. Awang, A.H. Hadi, W. Ekasari, A. Widyawaruyanti, and H. Morita. Bioorganic and Medicinal Chemistry Letters, 2011. 21(11): p. 3417-3419; PMID[21524573].
[Pubmed]. OI_0527-060911.
39. Aryl piperazine and pyrrolidine as Antimalarial Agents. Synthesis and Investigation of Structure-activity Relationships. Mendoza, A., S. Perez-Silanes, M. Quiliano, A. Pabon, S. Galiano, G. Gonzalez, G. Garavito, M. Zimic, A. Vaisberg, I. Aldana, A. Monge, and E. Deharo. Experimental Parasitology, 2011. 128(2): p. 97-103; PMID[21354139].
[Pubmed]. OI_0527-060911.
40. In vitro Antiplasmodial Activity of Ethanolic Extracts of Seaweed Macroalgae against Plasmodium falciparum. Ravikumar, S., S. Jacob Inbaneson, P. Suganthi, R. Gokulakrishnan, and M. Venkatesan. Parasitology Research, 2011. 108(6): p. 1411-6; PMID[21120527].
[Pubmed]. OI_0527-060911.
41. Mangrove Plants as a Source of Lead Compounds for the Development of New Antiplasmodial Drugs from South East Coast of India. Ravikumar, S., S. Jacob Inbaneson, P. Suganthi, M. Venkatesan, and A. Ramu. Parasitology Research, 2011. 108(6): p. 1405-1410; PMID[21120528].
[Pubmed]. OI_0527-060911.
Citations from the ISI Web of Knowledge Listings for O.I.
42. Identification, in Vitro Activity and Mode of Action of Phosphoinositide-Dependent-1 Kinase Inhibitors as Antifungal Molecules. Baxter, B.K., L. DiDone, D. Ogu, S. Schor, and D.J. Krysan. ACS Chemical Biology, 2011. 6(5): p. 502-510; ISI[000290747200015].
[WOS]. OI_0527-060911.
43. Antitubercular Activity of New Coumarins. Cardoso, S.H., M.B. Barreto, M.C.S. Lourenco, M. Henriques, A.L.P. Candea, C.R. Kaiser, and M.V.N. de Souza. Chemical Biology & Drug Design, 2011. 77(6): p. 489-493; ISI[000290587700010].
[WOS]. OI_0527-060911.
44. Structure-Activity Studies and Therapeutic Potential of Host Defense Peptides of Human Thrombin. Antimicrobial Agents and Chemotherapy. Kasetty, G., P. Papareddy, M. Kalle, V. Rydengard, M. Morgelin, B. Albiger, M. Malmsten, and A. Schmidtchen. Antimicrobial Agents and Chemotherapy, 2011. 55(6): p. 2880-2890; ISI[000290713400054].
[WOS]. OI_0527-060911.
45. Antimicrobial and Antioxidative Effects of Ugandan Medicinal Barks. Kuglerova, M., H. Tesarova, J.T. Grade, K. Halamova, O. Wanyana-Maganyi, P. Van Damme, and L. Kokoska. African Journal of Biotechnology, 2011. 10(18): p. 3628-3632; ISI[000290667500019].
[WOS]. OI_0527-060911.
46. Synthesis, Characterization and Antimicrobial Activity of New Cobalt (II), Nickel (II) and Copper (II) Complexes with 2-(2-Hydroxy-1, 2-diphenylethylideneamino) benzoic acid. Manikshete, A.H., S.K. Sarsamkar, S.A. Deodware, V.N. Kamble, and M.R. Asabe. Inorganic Chemistry Communications, 2011. 14(5): p. 618-621; ISI[000290460800002].
[WOS]. OI_0527-060911.
47. Short-term Antimicrobial Properties of Mineral Trioxide Aggregate with Incorporated Silver-zeolite. Odabas, M.E., C. Cinar, G. Akca, I. Araz, T. Ulusu, and H. Yucel. Dental Traumatology, 2011. 27(3): p. 189-194; ISI[000290541400006].
[WOS]. OI_0527-060911.
48. Synthesis, Spectroscopy and Biological Investigations of Manganese(III) Schiff base Complexes Derived from Heterocyclic Beta-diketone with Various Primary Amine and 2,2 '-Bipyridyl. Surati, K.R. Spectrochimica Acta Part a-Molecular and Biomolecular Spectroscopy, 2011. 79(1): p. 272-277; ISI[000290815400040].
[WOS]. OI_0527-060911.
49. Chemical Characterization and Biological Properties of NVC-422, a Novel, Stable N-Chlorotaurine Analog. Wang, L., B. Belisle, M. Bassiri, P. Xu, D. Debabov, C. Celeri, N. Alvarez, M.C. Robson, W.G. Payne, R. Najafi, and B. Khosrovi. Antimicrobial Agents and Chemotherapy, 2011. 55(6): p. 2688-2692; ISI[000290713400028].
[WOS]. OI_0527-060911.